FilmArray BCID Panel, RFIT-ASY-0126, 30, Rx Only, CE, IVD, UDI: 00815381020086 used with the following BACT/ALERT Blood Culture Bottle Catalog No./Description: 410851/BACT/ALERT® FA Plus 410852/BACT/ALERT® FN Plus 410853/BACT/ALERT® PF Plus 259790/BACT/ALERT® SN Product Usage: is a qualitative multiplexed nucleic acid-based in vitro diagnostic test intended for use with FilmArray systems.
Published June 17, 2020 · Recall initiated: January 22, 2020
Summary
FDA records medical device Class II recall Z-2295-2020, published June 17, 2020 and initiated January 22, 2020. Recalling firm: BioFire Diagnostics, LLC; Status: Terminated; Reported quantity: 18,501 kits; Lot: All lots of BioFire BCID Panel used with BACT/ALERT® blood culture bottles with expiration dates of September 19, 2020 and beyond. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
There is an increased risk of false positive Proteus results when using the Film Array Blood Culture Identification Panel (BCID) in vitro diagnostic test of blood cultures used in conjunction with specific media types. False positive Proteus results from this test may lead to patients receiving improper antibiotic treatment until culture results are available (within 24-48 hours).
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- BioFire Diagnostics, LLC
- Distributor
- Worldwide distribution - US Nationwide distribution and the countries of Argentina, Austria, Australia, Azerbaijan, Belgium, Bosnia-Herz., Botswana, Brazil, Bulgaria, Burkina Faso, Canada, Chile, Columbia, Costa Rica, Croatia, Czech Republic, Dominican Republic, Dutch Antilles, Ecuador, Egypt, El Salvador, Estonia, France, Gabon, Georgia, Germany, Greece, Guam, Guatemala, Honduras, Hong Kong, Hungary, India, Indonesia, Iraq, Israel, Italy, Ivory Coast, Japan, Kenya, Kuwait, Latvia, Lebanon, Lithuania, Malaysia, Mexico, Morocco, Myanmar, Netherlands, Nicaragua, Oman, Pakistan, Panama, Paraguay, Peru, Phillipines, Poland, Portugal, Romania, Saudi Arabia, Serbia, Singapore, Slovenia, South Africa, South Korea, Spain, Sweden, Sitzerland, Thailand, Tunisia, Turkey, United Kingdom, Uruguay, United Arab Emirates, Vietnam.
- Lot
- All lots of BioFire BCID Panel used with BACT/ALERT® blood culture bottles with expiration dates of September 19, 2020 and beyond.
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAGeneric Name: FilmArray® Pneumonia Panel Generic Name: FilmArray® Pneumonia Panel Model/Catalog Number:October 21, 2026
- FDAGeneric Name: FilmArray® Pneumonia Panel plus Generic Name: FilmArray® Pneumonia Panel plus Model/CatalogOctober 21, 2026
- FDAGeneric Name: BioFire® Joint Infection (JI) Panel Generic Name: BioFire® Joint Infection (JI) PanelOctober 21, 2026
- FDABIOFIRE Respiratory Panel 2.1 (RP2.1) REF 423742 UDI code: 00815381020529 PCR-based multiplexed nucleic acidAugust 19, 2026
- FDAtherascreen EGFR RGQ PCR Kit (24), Reference Number REF 870121June 17, 2020
- FDAMulti Display Manager in the Artis Systems (Image-Intensified Fluoroscopic X-Ray System) as follows: Artis QJune 17, 2020
Questions about this recall
Was FilmArray BCID Panel, RFIT-ASY-0126, 30, Rx Only, CE, IVD, UDI: 00815381020086 used with the following BACT/ALERT Blood Culture Bottle Catalog No./Description: 410851/BACT/ALERT® FA Plus 410852/BACT/ALERT® FN Plus 410853/BACT/ALERT® PF Plus 259790/BACT/ALERT® SN Product Usage: is a qualitative multiplexed nucleic acid-based in vitro diagnostic test intended for use with FilmArray systems. recalled?
Yes. FDA published recall Z-2295-2020 on June 17, 2020. Reported hazard: There is an increased risk of false positive Proteus results when using the Film Array Blood Culture Identification Panel (BCID) in vitro diagnostic test of blood cultures used in conjunction with specific media types. False positive Proteus results from this test may lead to patients receiving improper antibiotic treatment until culture results are available (within 24-48 hours).
What should I do if I have this product?
Voluntary: Firm initiated · Letter